American Financial Group Inc Iovance Biotherapeutics, Inc. Transaction History

American Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$27.21 - $41.0 $544,200 - $820,000	-20,000 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$17.95 - $29.41 $359,000 - $588,200	-20,000 Reduced 50.0%	20,000 $554,000
Q4 2018 Feb 13, 2019	BUY	$7.51 - $11.93 $150,200 - $238,600	20,000 Added 100.0%	40,000 $354,000
Q3 2018 Nov 09, 2018	BUY	$11.25 - $17.7 $225,000 - $354,000	20,000 New	20,000 $224,000

304

221M

3.05M

1.6M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.15B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of American Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on American Financial Group Inc with notifications on news.